Avricore Health (AVCRF) EPS (Basic) Growth (3y) (2012 - 2026)
Avricore Health (AVCRF) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -6.31% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 16.67% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 5.62% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -3.09% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 21.11% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 43.02% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.89% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.55% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | 6.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.73% |
| Dec 31, 2025 | -21.19% |
| Sep 30, 2025 | -24.22% |
| Jun 30, 2025 | -25.12% |
| Mar 31, 2025 | -607.58% |
| Sep 30, 2024 | -1,600.08% |
| Jun 30, 2024 | 80.44% |
| Mar 31, 2024 | 137.93% |
| Dec 31, 2023 | 15,833.21% |
| Dec 31, 2022 | -22,221.33% |
| Dec 31, 2021 | 42.23% |
| Sep 30, 2021 | 76.08% |
| Jun 30, 2021 | 99.71% |
| Dec 31, 2020 | 99.86% |
| Dec 31, 2019 | 99.87% |
| Sep 30, 2018 | -36.22% |
| Dec 31, 2017 | -1,626.18% |
| Sep 30, 2017 | -67.92% |
| Dec 31, 2016 | -2,394.32% |
| Sep 30, 2016 | 30.87% |